13F filer · CIK 1344551 ↗
Assetmark, Inc
You are looking at Q2 2022. See the latest, Q3 2026 →
Reported value
$22.31B
−6.6% on the quarter before
Positions
1,558
127 new · 189 sold out
Top 10
32.2%
of the value
Est. gain
−$2.70B
on stocks held all quarter
Est. return
−12.1%
on those stocks since Q1 2022
Positions as of Jun 30, 2022, from Assetmark, Inc's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 49% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2022. Striped tiles are options.
Largest buys
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- SPDR Ser Tr Bloomberg 1-3 Mo~$337.7MAdded · 2.4% → 4.1%+3,691,004 shares
- Vanguard Scottsdale Fds Short Term Treas~$167.1MAdded · 0.1% → 0.9%+2,838,416 shares
- Ishares Tr 1 3 Yr Treas Bd~$133.3MAdded · 4.6% → 5.5%+1,609,698 shares
- J P Morgan Exchange Traded F Intrnl Res Eqt~$132.4MNew · 0.0% → 0.6%+2,741,875 shares
- SPDR Gold Tr Gold Shs~$130.8MAdded · 0.1% → 0.7%+776,491 shares
- Vanguard Scottsdale Fds Mtg-Bkd Secs ETF~$126.8MAdded · 1.3% → 1.9%+2,652,216 shares
- Ishares Tr Short Treas Bd~$113.8MAdded · 0.8% → 1.4%+1,033,957 shares
- Ishares Tr Us Hlthcr Pr ETF~$74.9MNew · 0.0% → 0.3%+293,312 shares
- Ishares Tr U.S. Med Dvc ETF~$72.6MAdded · 0.0% → 0.3%+1,438,734 shares
- First Tr Exchange-Traded Fd Dj Internt Idx~$67.9MAdded · 0.0% → 0.3%+534,477 shares
Largest sells
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Ishares Tr Gov/Cred Bd ETF~$153.1MCut · 0.7% → 0.0%−1,421,655 shares
- Ishares Tr 10-20 Yr Trs ETF~$141.8MCut · 0.7% → 0.0%−1,180,148 shares
- Ishares Tr 7-10 Yr Trsy Bd~$83.2MCut · 0.9% → 0.5%−813,018 shares
- Nushares ETF Tr Nuveen Enhnc Yld~$78.6MCut · 0.7% → 0.3%−3,650,845 shares
- SPDR Ser Tr Portfolio Sh Tsr~$76.8MCut · 0.7% → 0.4%−2,608,905 shares
- SPDR Ser Tr S&P Biotech~$73.3MCut · 0.4% → 0.0%−994,557 shares
- Ishares Tr Residential Mult~$73.3MCut · 0.4% → 0.0%−904,390 shares
- Ishares Tr Usd Inv Grde ETF~$69.7MCut · 0.8% → 0.5%−1,368,259 shares
- Ishares Tr Eafe Value ETF~$59.7MCut · 0.3% → 0.0%−1,376,615 shares
- Ishares Tr Iboxx Hi Yd ETF~$53.9MCut · 0.3% → 0.0%−732,338 shares
Holdings
As of Jun 30, 2022. Changes are in shares against Mar 31, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ishares Tr 1 3 Yr Treas Bd1 3 YR TREAS BD · shares +12% · price −0.7% | 5.5% | $1.23B | −$7.4M | ||||||||
| Vanguard Index Fds S&P 500 ETF ShsS&P 500 ETF SHS · shares +0.9% · price −16.4% | 4.7% | $1.05B | −$205.3M | ||||||||
| Vanguard World Fd Mega Grwth IndMEGA GRWTH IND · shares +6.9% · price −22.8% | 4.6% | $1.02B | −$280.9M | ||||||||
| Vanguard World Fd Mega Cap Val ETFMEGA CAP VAL ETF · shares +3.4% · price −10.4% | 4.3% | $959.5M | −$107.5M | ||||||||
| SPDR Ser Tr Bloomberg 1-3 MoBLOOMBERG 1-3 MO · shares +59% · price +0.1% | 4.1% | $909.5M | +$375,018 | ||||||||
| Vanguard Index Fds Sm Cp Val ETFSM CP VAL ETF · shares +4.1% · price −14.8% | 2.0% | $435.7M | −$73.0M | ||||||||
| Vanguard Scottsdale Fds Mtg-Bkd Secs ETFMTG-BKD SECS ETF · shares +42% · price −4.6% | 1.9% | $431.5M | −$14.6M | ||||||||
| Ishares Tr Core Msci EafeCORE MSCI EAFE · shares +0.3% · price −15.3% | 1.8% | $402.4M | −$72.7M | ||||||||
| Ishares Tr Ishs 1-5yr InvsISHS 1-5YR INVS · shares +11% · price −2.3% | 1.7% | $379.2M | −$7.9M | ||||||||
| Ishares Inc Core Msci EmktCORE MSCI EMKT · shares +6.2% · price −11.7% | 1.7% | $375.7M | −$46.8M | ||||||||
| Ishares Tr Iboxx Inv Cp ETFIBOXX INV CP ETF · shares +10% · price −9.0% | 1.6% | $364.5M | −$32.7M | ||||||||
| Ishares Tr Us Treas Bd ETFUS TREAS BD ETF · shares −1.6% · price −4.1% | 1.4% | $318.4M | −$13.5M | ||||||||
| Vanguard Index Fds Mcap Vl IdxvipMCAP VL IDXVIP · shares +4.0% · price −13.5% | 1.4% | $310.8M | −$46.5M | ||||||||
| Ishares Tr Short Treas BdSHORT TREAS BD · shares +59% · price −0.1% | 1.4% | $306.1M | −$261,795 | ||||||||
| Vanguard Index Fds Mcap Gr IdxvipMCAP GR IDXVIP · shares +6.4% · price −21.3% | 1.2% | $272.9M | −$69.3M | ||||||||
| Ishares Tr Ishs 5-10yr InvtISHS 5-10YR INVT · shares −1.4% · price −6.9% | 1.2% | $259.9M | −$19.4M | ||||||||
| Vanguard Charlotte Fds Total Int Bd ETFTOTAL INT BD ETF · shares −1.7% · price −5.5% | 1.2% | $257.1M | −$15.0M | ||||||||
| Vanguard Bd Index Fds Total Bnd MrktTOTAL BND MRKT · shares +11% · price −5.4% | 1.1% | $253.0M | −$13.0M | ||||||||
| MicrosoftCOM · shares +6.0% · price −16.7% | 1.1% | $241.6M | −$45.7M | ||||||||
| Ishares Tr 0-5yr Hi Yl Cp0-5YR HI YL CP · shares +39% · price −7.8% | 1.1% | $239.9M | −$14.5M | ||||||||
| Ishares Tr 3 7 Yr Treas Bd3 7 YR TREAS BD · shares −3.0% · price −2.2% | 1.0% | $233.6M | −$5.3M | ||||||||
| Ishares Tr Tips Bd ETFTIPS BD ETF · shares +3.5% · price −8.6% | 1.0% | $224.2M | −$20.3M | ||||||||
| Vanguard Index Fds Sml Cp Grw ETFSML CP GRW ETF · shares +10% · price −20.6% | 0.97% | $217.4M | −$51.2M | ||||||||
| Vanguard Index Fds Value ETFVALUE ETF · shares −5.6% · price −10.8% | 0.94% | $210.1M | −$25.3M | ||||||||
| AppleCOM · shares +3.6% · price −21.7% | 0.89% | $197.7M | −$52.9M | ||||||||
| Total · 1,558 positions | 100% | $22.31B | −$2.70B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2022 to Q2 2022: 1,354 stocks held throughout, down $2.70B (−12.1%).
- United Therapeutics Corp Del Com+$11.9M+31%
- Eli Lilly+$6.3M+13%
- General Mls Inc Com+$3.7M+11%
- Sanderson Farms Inc Com+$3.4M+15%
- Gilead Sciences Inc Com+$2.9M+4%
- Ishares Tr Core Msci Eafe−$72.7M−15%
- Vanguard Index Fds Sm Cp Val ETF−$73.0M−15%
- Vanguard World Fd Mega Cap Val ETF−$107.5M−10%
- Vanguard Index Fds S&P 500 ETF Shs−$205.3M−16%
- Vanguard World Fd Mega Grwth Ind−$280.9M−23%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 8 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Oct 21, 2026 | $59.48B+2% | SEC ↗ |
| Q2 2026 | Jul 30, 2026 | $58.17B+19% | SEC ↗ |
| Q1 2026 | May 6, 2026 | $49.04B+0% | SEC ↗ |
| Q4 2025 | Jan 23, 2026 | $49.04B+5% | SEC ↗ |
| Q3 2025 | Nov 6, 2025 | $46.65B+10% | SEC ↗ |
| Q2 2025 | Aug 4, 2025 | $42.36B+16% | SEC ↗ |
| Q1 2025 | May 6, 2025 | $36.41B−1% | SEC ↗ |
| Q4 2024 | Feb 6, 2025 | $36.81B+5% | SEC ↗ |
| Q3 2024 | Nov 1, 2024 | $34.92B+8% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $32.33B+5% | SEC ↗ |
| Q1 2024 | May 7, 2024 | $30.76B+11% | SEC ↗ |
| Q4 2023 | Feb 9, 2024 | $27.67B+11% | SEC ↗ |
| Q3 2023 | Oct 27, 2023 | $25.01B−2% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $25.49B+5% | SEC ↗ |
| Q1 2023 | May 5, 2023 | $24.19B+5% | SEC ↗ |
| Q4 2022 | Feb 10, 2023 | $23.07B+8% | SEC ↗ |
| Q3 2022 | Nov 1, 2022 | $21.39B−4% | SEC ↗ |
| Q2 2022 | Aug 3, 2022 | $22.31B−7% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $23.89B−2% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $24.34B+9% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $22.32B+4% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $21.56B+11% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $19.39B+8% | SEC ↗ |
| Q4 2020 | Feb 10, 2021 | $17.95B+16% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $15.50B+11% | SEC ↗ |
| Q2 2020 | Aug 11, 2020 | $13.98B+18% | SEC ↗ |
| Q1 2020 | May 12, 2020 | $11.81B−10% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $13.16B+10% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $11.95B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $12.27B+11% | SEC ↗ |
| Q1 2019 | May 14, 2019 | $11.07B+7% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 | $10.36B−6% | SEC ↗ |
| Q3 2018 | Nov 13, 2018 | $11.00B+8% | SEC ↗ |
| Q2 2018 | Aug 1, 2018 | $10.18B+5% | SEC ↗ |
| Q1 2018 | May 16, 2018 | $9.66B−0% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $9.70B+10% | SEC ↗ |
| Q3 2017 | Nov 8, 2017 | $8.79B+11% | SEC ↗ |
| Q2 2017 | Aug 15, 2017 | $7.95B+4% | SEC ↗ |
| Q1 2017 | Sep 15, 2017 (amended) | $7.61B+12% | SEC ↗ |
| Q4 2016 | Sep 15, 2017 (amended) | $6.81B+4% | SEC ↗ |
| Q3 2016 | Sep 15, 2017 (amended) | $6.58B+11% | SEC ↗ |
| Q2 2016 | Sep 15, 2017 (amended) | $5.95B+4% | SEC ↗ |
| Q1 2016 | Sep 15, 2017 (amended) | $5.73B | SEC ↗ |